Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,689 across all filing types
Latest filing 2021-09-30 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
迪瑞医疗:公司章程
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of 迪瑞医疗科技股份有限公司 (Dirui Medical Technology Co., Ltd.). It contains detailed provisions about the company's organization, shareholder rights, board of directors, management, financial accounting, profit distribution, and other governance matters. The content is consistent with a company's internal governance rules and bylaws. There is no indication that this is an annual report, financial statement, audit report, or any other type of financial or regulatory filing. Instead, it is a governance document outlining the company's structure and rules. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed content support this classification with high confidence.
2021-09-30 Chinese
关于召开2021年第二次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about convening the 2021 second extraordinary general meeting of shareholders for Dirui Medical Technology Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), agenda items for shareholder approval, registration methods, and proxy forms. The content focuses on the announcement and procedural details for the shareholders' meeting rather than the results of the meeting or the minutes. There is no indication that this is a report of voting results or a summary of the meeting outcomes. The document is not a financial report, audit, or earnings release. It is a formal notification to shareholders about the meeting and how to participate, which fits the definition of AGM Information (AGM-R). The document length is about 4637 characters, which is consistent with a detailed meeting notice rather than a brief announcement or a full report.
2021-09-22 Chinese
迪瑞医疗:关于公司第五届董事会第七次临时会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors regarding the company's fifth board of directors' seventh extraordinary meeting. It discusses the election and appointment of a new director and senior management personnel, including qualifications and compliance with relevant laws and regulations. There is no financial data, earnings information, or report publication mentioned. The content focuses on board and management changes. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2021-09-22 Chinese
关于补选公司董事及聘任总经理的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company director and the appointment of a new director and general manager. It includes details about board changes, compliance with regulatory requirements, and official statements from the board. There is no financial data, earnings information, or report publication mentioned. The content clearly fits the category of Board/Management Information, as it concerns changes in the company's board of directors and senior management.
2021-09-22 Chinese
第五届董事会第七次临时会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of resolutions passed at a board meeting, specifically about the appointment of a new general manager and the resignation and replacement of a board director. It includes voting results and mentions upcoming shareholder meetings. There are no financial statements or detailed financial data. The content focuses on board and senior management changes. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report or presentation but an official announcement of management changes.
2021-09-22 Chinese
关于公司获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of medical device registration certificates issued by a regulatory authority (Jilin Province Drug Administration). It details the registration certificates for specific medical devices, their validity periods, and clinical uses. The document is short (900 characters) and serves as an official announcement of regulatory approval rather than a financial report or detailed filing. It does not contain financial data, management changes, voting results, or other report types. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about product registration certificates, which does not fall into other specific categories.
2021-09-17 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.